MedTrace Logo

Prostate Accurately Targeted Radiotherapy Investigation of Overall Treatment Time

NCT01423474 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 152

Last updated 2024-02-23

No results posted yet for this study

Summary

The purpose of this study is to compare the toxicity of two new radiation schedules for the treatment of prostate cancer. Patients will be randomized to receive 5 treatments delivered every other day over 11 days, or once per week over 29 days. Both of these schedules are shorter than the standard treatment which is usually 39 treatments over 8 weeks.

Conditions

  • Prostatic Neoplasms

Interventions

RADIATION

Image-guided radiotherapy

40 Gy / 5 fractions / 11 days

RADIATION

Image-guided radiotherapy

40 Gy / 5 fractions / 29 days

Sponsors & Collaborators

  • Sunnybrook Health Sciences Centre

    collaborator OTHER

  • British Columbia Cancer Agency

    collaborator OTHER

  • CancerCare Manitoba

    lead OTHER

Principal Investigators

  • Aldrich Ong, MD · CancerCare Manitoba

  • Andrew Loblaw, MD · Sunnybrook Health Sciences Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2019-08-31
Completion
2019-08-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01423474 on ClinicalTrials.gov